Dose-Attenuated-Polatuzumab Vedotine plus CHP vs. Dose-Attenuated -R-CHOP in Patients Aged ≥ 80 Years with Diffuse Large B-Cell Lymphoma: A Retrospective, Propensity Score-Matched Analysis Stratified by Simplified Frailty Score. [PDF]
Sato S +5 more
europepmc +1 more source
Genomic Surveillance of 3R Genes Associated with Antibiotic Resistance in Mycobacterium tuberculosis Isolates from Kazakhstan. [PDF]
Timochshuk S +7 more
europepmc +1 more source
Overlap MCAP-CLAPO syndrome associated with malignant ovarian tumor in a 11 year old girl. [PDF]
Cerro Rodríguez DD +4 more
europepmc +1 more source
Efficacy of Pola-R-CHP and Autologous Stem Cell Transplantation in Untreated Burkitt Lymphoma: A Case Report. [PDF]
Yang Y, Ren Y, Li J, Liu P.
europepmc +1 more source
Strategic Combinations of Antibody-Drug Conjugates from 2023 to 2025: From Dual Therapies to Innovative ADC-Based Regimens. [PDF]
Jang H, Chang JE.
europepmc +1 more source
The effects of bleaching products on the color stability of ion-releasing restoratives. [PDF]
Lee JS, Yahya NA, Abdul Aziz A, Yap AU.
europepmc +1 more source
Bispecific Monoclonal Antibodies in Diffuse Large B-Cell Lymphoma: Dawn of a New Era in Targeted Therapy. [PDF]
Schipani M +9 more
europepmc +1 more source

